Uninephrectomy augments the effects of high fat diet induced obesity on gene expression in mouse kidney

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 9, 2014, Pages 1870-1878

  Gai, Zhibo ^a   Hiller, Christian ^a   Chin, Siew Hung ^b,c   Hofstetter, Lia ^a   Stieger, Bruno ^a   Konrad, Daniel ^b,c   Kullak Ublick, Gerd A ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Bile acids; BMP pathway; Gene regulation; Nuclear receptor; Organic anion transporter; Wnt signaling

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; FARNESOID X RECEPTOR; HYDROGEN PEROXIDE; TRIACYLGLYCEROL; MESSENGER RNA; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A1;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APICAL MEMBRANE; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL ADHESION; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; GENE EXPRESSION; GLOMERULOSCLEROSIS; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; ION TRANSPORT; KIDNEY; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; LIPID DIET; LIPID METABOLISM; LIPID TRANSPORT; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; UNINEPHRECTOMY; WNT SIGNALING PATHWAY; ANIMAL TISSUE; DISEASE COURSE; DISEASE PREDISPOSITION; KIDNEY DISEASE; MICROARRAY ANALYSIS; NEPHRON; SHAM PROCEDURE;

BILE ACIDS; BMP PATHWAY; GENE REGULATION; NUCLEAR RECEPTOR; ORGANIC ANION TRANSPORTER; WNT SIGNALING;

ANIMALS; BIOLOGICAL MARKERS; DIET, HIGH-FAT; FIBROSIS; GENE EXPRESSION PROFILING; KIDNEY DISEASES; MALE; MICE; MICE, INBRED C57BL; NEPHRECTOMY; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84904490449     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.07.001     Document Type: Article

References (49)

1. Cheng H.Y. Midlife body mass index and total mortality. JAMA 2006, 295:1772. (author reply 1772.).
2. Hu F.B., Willett W.C., Li T., Stampfer M.J., Colditz G.A., Manson J.E. Adiposity as compared with physical activity in predicting mortality among women. N. Engl. J. Med. 2004, 351:2694-2703.
3. Praga M., Morales E. Obesity, proteinuria and progression of renal failure. Curr. Opin. Nephrol. Hypertens. 2006, 15:481-486.
4. Wang Y., Chen X., Song Y., Caballero B., Cheskin L.J. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008, 73:19-33.
5. Kambham N., Markowitz G.S., Valeri A.M., Lin J., D'Agati V.D. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001, 59:1498-1509.
6. Gonzalez E., Gutierrez E., Morales E., Hernandez E., Andres A., Bello I., Diaz-Gonzalez R., Leiva O., Praga M. Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int. 2005, 68:263-270.
7. Hall J.E., Crook E.D., Jones D.W., Wofford M.R., Dubbert P.M. Mechanisms of obesity-associated cardiovascular and renal disease. Am. J. Med. Sci. 2002, 324:127-137.
8. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., Go A.S. Body mass index and risk for end-stage renal disease. Ann. Intern. Med. 2006, 144:21-28.
9. Praga M., Hernandez E., Herrero J.C., Morales E., Revilla Y., Diaz-Gonzalez R., Rodicio J.L. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int. 2000, 58:2111-2118.
10. Akl K. The anomalies associated with congenital solitary functioning kidney in children. Saudi J. Kidney Dis. Transpl. 2011, 22:67-71.
11. Dhote R., Thiounn N., Debre B., Vidal-Trecan G. Risk factors for adult renal cell carcinoma. Urol. Clin. North Am. 2004, 31:237-247.
12. Hiraoka M., Tsukahara H., Ohshima Y., Kasuga K., Ishihara Y., Mayumi M. Renal aplasia is the predominant cause of congenital solitary kidneys. Kidney Int. 2002, 61:1840-1844.
13. Mandelbrot D.A., Pavlakis M. Living donor practices in the United States. Adv. Chronic Kidney Dis. 2012, 19:212-219.
14. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
15. Raj M., Kumar R.K. Obesity in children & adolescents. Indian J. Med. Res. 2010, 132:598-607.
16. Coimbra T.M., Janssen U., Grone H.J., Ostendorf T., Kunter U., Schmidt H., Brabant G., Floege J. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int. 2000, 57:167-182.
17. Wu Y., Liu Z., Xiang Z., Zeng C., Chen Z., Ma X., Li L. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006, 147:44-50.
18. Gotoh K., Inoue M., Masaki T., Chiba S., Shiraishi K., Shimasaki T., Matsuoka K., Ando H., Fujiwara K., Fukunaga N., Aoki K., Nawata T., Katsuragi I., Kakuma T., Seike M., Yoshimatsu H. Obesity-related chronic kidney disease is associated with spleen-derived IL-10. Nephrol. Dial. Transplant. 2013, 28:1120-1130.
19. Decleves A.E., Mathew A.V., Cunard R., Sharma K. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 2011, 22:1846-1855.
20. Kume S., Uzu T., Araki S., Sugimoto T., Isshiki K., Chin-Kanasaki M., Sakaguchi M., Kubota N., Terauchi Y., Kadowaki T., Haneda M., Kashiwagi A., Koya D. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J. Am. Soc. Nephrol. 2007, 18:2715-2723.
21. Odermatt A. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am. J. Physiol. Renal Physiol. 2011, 301:F919-F931.
22. Stemmer K., Perez-Tilve D., Ananthakrishnan G., Bort A., Seeley R.J., Tschop M.H., Dietrich D.R., Pfluger P.T. High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney. Dis. Model Mech. 2012, 5:627-635.
23. Bhavnani S.K., Eichinger F., Martini S., Saxman P., Jagadish H.V., Kretzler M. Network analysis of genes regulated in renal diseases: implications for a molecular-based classification. BMC Bioinformatics 2009, 10(Suppl. 9):S3.
24. Du R., Sun W., Xia L., Zhao A., Yu Y., Zhao L., Wang H., Huang C., Sun S. Hypoxia-induced down-regulation of microRNA-34a promotes EMT by targeting the Notch signaling pathway in tubular epithelial cells. PLoS ONE 2012, 7:e30771.
25. Granata S., Zaza G., Simone S., Villani G., Latorre D., Pontrelli P., Carella M., Schena F.P., Grandaliano G., Pertosa G. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 2009, 10:388.
26. Sapienza C., Lee J., Powell J., Erinle O., Yafai F., Reichert J., Siraj E.S., Madaio M. DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy. Epigenetics 2011, 6:20-28.
27. Schanstra J.P., Bachvarova M., Neau E., Bascands J.L., Bachvarov D. Gene expression profiling in the remnant kidney model of wild type and kinin B1 and B2 receptor knockout mice. Kidney Int. 2007, 72:442-454.
28. Gai Z., Zhou G., Gui T., Itoh S., Oikawa K., Uetani K., Muragaki Y. Trps1 haploinsufficiency promotes renal fibrosis by increasing Arkadia expression. J. Am. Soc. Nephrol. 2010, 21:1468-1476.
29. Zheng S., Huang Y., Yang L., Chen T., Xu J., Epstein P.N. Uninephrectomy of diabetic OVE26 mice greatly accelerates albuminuria, fibrosis, inflammatory cell infiltration and changes in gene expression. Nephron Exp. Nephrol. 2011, 119:e21-e32.
30. Praga M., Hernandez E., Morales E., Campos A.P., Valero M.A., Martinez M.A., Leon M. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol. Dial. Transplant. 2001, 16:1790-1798.
31. Chagnac A., Weinstein T., Korzets A., Ramadan E., Hirsch J., Gafter U. Glomerular hemodynamics in severe obesity. Am. J. Physiol. Renal Physiol. 2000, 278:F817-F822.
32. Nogueira J.M., Weir M.R., Jacobs S., Breault D., Klassen D., Evans D.A., Bartlett S.T., Cooper M. A study of renal outcomes in obese living kidney donors. Transplantation 2010, 90:993-999.
33. Attman P.O., Samuelsson O., Alaupovic P. Progression of renal failure: role of apolipoprotein B-containing lipoproteins. Kidney Int. Suppl. 1997, 63:S98-S101.
34. Fiorucci S., Rizzo G., Antonelli E., Renga B., Mencarelli A., Riccardi L., Orlandi S., Pruzanski M., Morelli A., Pellicciari R. A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis. J. Pharmacol. Exp. Ther. 2005, 314:584-595.
35. Wang X.X., Jiang T., Shen Y., Caldas Y., Miyazaki-Anzai S., Santamaria H., Urbanek C., Solis N., Scherzer P., Lewis L., Gonzalez F.J., Adorini L., Pruzanski M., Kopp J.B., Verlander J.W., Levi M. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes 2010, 59:2916-2927.
36. Wang X.X., Jiang T., Shen Y., Adorini L., Pruzanski M., Gonzalez F.J., Scherzer P., Lewis L., Miyazaki-Anzai S., Levi M. The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am. J. Physiol. Renal Physiol. 2009, 297:F1587-F1596.
37. Hu Z., Ren L., Wang C., Liu B., Song G. Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed Wistar rats. Kidney Blood Press. Res. 2012, 36:85-97.
38. Gai Z., Chu L., Hiller C., Arsenijevic D., Penno C.A., Montani J.P., Odermatt A., Kullak-Ublick G.A. Effect of chronic renal failure on the hepatic, intestinal, and renal expression of bile acid transporters. Am. J. Physiol. Renal Physiol. 2014, 306:F130-F137.
39. Jung D., Kullak-Ublick G.A. Hepatocyte nuclear factor 1 alpha: a key mediator of the effect of bile acids on gene expression. Hepatology 2003, 37:622-631.
40. Popowski K., Eloranta J.J., Saborowski M., Fried M., Meier P.J., Kullak-Ublick G.A. The human organic anion transporter 2 gene is transactivated by hepatocyte nuclear factor-4 alpha and suppressed by bile acids. Mol. Pharmacol. 2005, 67:1629-1638.
41. Fickert P., Krones E., Pollheimer M.J., Thueringer A., Moustafa T., Silbert D., Halilbasic E., Yang M., Jaeschke H., Stokman G., Wells R.G., Eller K., Rosenkranz A.R., Eggertsen G., Wagner C.A., Langner C., Denk H., Trauner M. Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice. Hepatology 2013, 58:2056-2069.
42. Decleves A.E., Zolkipli Z., Satriano J., Wang L., Nakayama T., Rogac M., Le T.P., Nortier J.L., Farquhar M.G., Naviaux R.K., Sharma K. Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury. Kidney Int. 2014, 85:611-623.
43. Delanaye P., Weekers L., Dubois B.E., Cavalier E., Detry O., Squifflet J.P., Krzesinski J.M. Outcome of the living kidney donor. Nephrol. Dial. Transplant. 2012, 27:41-50.
44. Westenend P.J., Nooyen Y.A., van der Krogt J.A., van Brummelen P., Weening J.J. Functional and structural determinants of glomerulosclerosis in the fawn-hooded rat. Eur. J. Clin. Invest. 1992, 22:391-395.
45. Ninichuk V., Kulkarni O., Clauss S., Anders H. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy. Eur. J. Med. Res. 2007, 12:351-355.
46. Navaneethan S.D., Yehnert H., Moustarah F., Schreiber M.J., Schauer P.R., Beddhu S. Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis. Clin. J. Am. Soc. Nephrol. 2009, 4:1565-1574.
47. Nangaku M., Izuhara Y., Usuda N., Inagi R., Shibata T., Sugiyama S., Kurokawa K., Van Ypersele de Strihou C., Miyata T. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol. Dial. Transplant. 2005, 20:2661-2669.
48. Ohtomo S., Izuhara Y., Nangaku M., Dan T., Ito S., van Ypersele de Strihou C., Miyata T. Body weight control by a high-carbohydrate/low-fat diet slows the progression of diabetic kidney damage in an obese, hypertensive, type 2 diabetic rat model. J. Obes. 2010, 2010.
49. Davis C.L., Cooper M. The state of U.S. living kidney donors. Clin. J. Am. Soc. Nephrol. 1873-1880, 5(2010).